CEO & Co-Founder
Nomic Bio, Quebec, Canada
Milad is the Co-founder and CEO of Nomic Bio, a bioengineering company that's commercializing the nELISA: the world's highest throughput proteomic platform. During his PhD at McGill University, Milad developed enabling tools that leverage DNA nanotechnology, high-dimensional flow cytometry, and machine learning which became the technological basis for the nELISA. Milad has since led the company through its spin-out from McGill as well as through multiple rounds of financing totalling $21M from top tier venture capital firms including Y-Combinator and Lux Capital.
Disclosure information not submitted.
Tuesday, February 8, 2022
1:00 PM – 1:30 PM